SMS Lifesciences India Limited (SMSLIFE.BO)
INR 1664.9
(16.32%)
INR 1664.9
(16.32%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 602.96 Million INR | -74.76% |
| 2022 | 664.98 Million INR | 5.74% |
| 2021 | 628.88 Million INR | 31.49% |
| 2020 | 478.27 Million INR | 17.02% |
| 2019 | 408.69 Million INR | 6.62% |
| 2018 | 383.33 Million INR | 33.03% |
| 2017 | 288.15 Million INR | 5.74% |
| 2016 | 272.49 Million INR | 1472862.16% |
| 2015 | 18.5 Thousand INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 22.31 Million INR | 148.8% |
| 2023 Q3 | 203.67 Million INR | 2.19% |
| 2023 FY | 167.82 Million INR | -74.76% |
| 2023 Q2 | 199.3 Million INR | 7.98% |
| 2023 Q1 | 184.57 Million INR | 14.27% |
| 2023 Q4 | 57.79 Million INR | -71.62% |
| 2022 Q2 | 162.28 Million INR | -1.67% |
| 2022 Q3 | 180.67 Million INR | 11.33% |
| 2022 Q4 | 161.52 Million INR | -10.6% |
| 2022 Q1 | 165.05 Million INR | 13.9% |
| 2022 FY | 664.98 Million INR | 5.74% |
| 2021 Q4 | 144.91 Million INR | -18.02% |
| 2021 FY | 628.88 Million INR | 31.49% |
| 2021 Q2 | 171.81 Million INR | 20.26% |
| 2021 Q1 | 142.87 Million INR | 40.16% |
| 2021 Q3 | 176.76 Million INR | 2.88% |
| 2020 Q2 | 138.48 Million INR | 21.09% |
| 2020 FY | 478.27 Million INR | 17.02% |
| 2020 Q1 | 114.36 Million INR | 52.49% |
| 2020 Q3 | 127.9 Million INR | -7.64% |
| 2020 Q4 | 101.93 Million INR | -20.3% |
| 2019 Q2 | 123.64 Million INR | 15.67% |
| 2019 FY | 408.69 Million INR | 6.62% |
| 2019 Q4 | 74.99 Million INR | -27.36% |
| 2019 Q3 | 103.24 Million INR | -16.5% |
| 2019 Q1 | 106.89 Million INR | 11.18% |
| 2018 Q1 | 95.48 Million INR | 4.01% |
| 2018 FY | 383.33 Million INR | 33.03% |
| 2018 Q4 | 96.14 Million INR | -13.09% |
| 2018 Q3 | 110.62 Million INR | 20.9% |
| 2018 Q2 | 91.49 Million INR | -4.17% |
| 2017 Q3 | 79.95 Million INR | 1.31% |
| 2017 Q4 | 91.79 Million INR | 14.81% |
| 2017 FY | 288.15 Million INR | 5.74% |
| 2017 Q1 | 79.91 Million INR | -13.54% |
| 2017 Q2 | 78.91 Million INR | -1.25% |
| 2016 Q1 | 203.14 Million INR | 0.0% |
| 2016 Q3 | 225.76 Million INR | 16.7% |
| 2016 Q2 | 193.44 Million INR | -4.77% |
| 2016 FY | 272.49 Million INR | 1472862.16% |
| 2016 Q4 | 92.42 Million INR | -59.06% |
| 2015 FY | 18.5 Thousand INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | -48526.371% |
| Biocon Limited | 40.9 Billion INR | 98.526% |
| Blue Jet Healthcare Limited | 531.85 Million INR | -13.372% |
| Concord Biotech Limited | 1.45 Billion INR | 58.692% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | 88.286% |
| FERMENTA BIOTECH LIMITED | 754.2 Million INR | 20.053% |
| GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -160691.2% |
| Lyka Labs Limited | 599.4 Million INR | -0.594% |
| Panacea Biotec Limited | 1.99 Billion INR | 69.782% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | -40168.135% |
| Servoteach Industries Limited | 785.00 INR | -76810982.803% |
| Supriya Lifescience Limited | 1.08 Billion INR | 44.177% |
| Syngene International Limited | 5.99 Billion INR | 89.942% |
| TAKE Solutions Limited | 396.91 Million INR | -51.915% |
| Titan Biotech Limited | 117.05 Million INR | -415.105% |
| Transgene Biotek Limited | 5.39 Million INR | -11072.262% |
| Vanta Bioscience Limited | 38.95 Million INR | -1447.736% |